US 11,738,192 B2
Neurostimulation device
André Mercanzini, Saint Sulpice (CH); Zbynek Struzka, Lausanne (CH); Jason Jinyu Ruan, Lausanne (CH); Pascal Harbi, Lausanne (CH); and Alain Jordan, Lausanne (CH)
Assigned to Aleva Neurotherapeutics
Filed by Aleva Neurotherapeutics, Lausanne (CH)
Filed on Feb. 8, 2022, as Appl. No. 17/667,052.
Application 17/667,052 is a continuation of application No. 16/901,583, filed on Jun. 15, 2020, granted, now 11,266,830.
Application 16/901,583 is a continuation of application No. 15/910,278, filed on Mar. 2, 2018, granted, now 10,702,692, issued on Jul. 7, 2020.
Prior Publication US 2022/0161024 A1, May 26, 2022
Int. Cl. A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61B 90/00 (2016.01)
CPC A61N 1/0539 (2013.01) [A61N 1/0534 (2013.01); A61N 1/0551 (2013.01); A61N 1/3605 (2013.01); A61B 2090/3966 (2016.02)] 20 Claims
OG exemplary drawing
 
1. A stimulation lead device, comprising:
a microelectrode film, the microelectrode film including an extension;
a support comb, the support comb including:
an attachment face to couple with the extension of the microelectrode film;
a slot to receive a wire; and
a first finger and a second finger that define a channel, the channel to receive the wire.